Cavernous haemangioma with Kasabach-Merritt syndrome: treatment with alpha-interferon

J J Ettlinger1, P J Fleming, H S Joffe

  • 1Department of Neonatal and Intensive Care Medicine, Royal Hospital for Sick Children, Bristol, England.

Insights

Serious complications like Kasabach-Merritt syndrome can arise in infants with haemangioma. This report details the successful management of an infant experiencing this rare syndrome.

Area of Science:

  • Pediatric Oncology
  • Vascular Malformations

Background:

  • Infantile haemangiomas are common benign vascular tumors.
  • A subset of patients develop life-threatening complications.
  • Kasabach-Merritt syndrome is a rare but severe complication characterized by thrombocytopenia and coagulopathy.